BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23478912)

  • 1. Vaccine and immunotherapeutic interventions.
    Pantaleo G; Lévy Y
    Curr Opin HIV AIDS; 2013 May; 8(3):236-42. PubMed ID: 23478912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Immune Interventions for an HIV-1 Cure.
    Perreau M; Banga R; Pantaleo G
    Trends Mol Med; 2017 Oct; 23(10):945-961. PubMed ID: 28890135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune interventions in HIV infection.
    Carcelain G; Autran B
    Immunol Rev; 2013 Jul; 254(1):355-71. PubMed ID: 23772631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV).
    Boström AC; Hejdeman B; Matsuda R; Fredriksson M; Fredriksson EL; Bratt G; Sandström E; Wahren B
    Vaccine; 2004 Apr; 22(13-14):1683-91. PubMed ID: 15068851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy as an adjunct to highly-active antiretroviral therapy.
    Murphey-Corb M; Heydenburg-Fuller D
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1191-7. PubMed ID: 11717803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy and therapeutic vaccines in HIV infection.
    García F; Ruiz L; López-Bernaldo de Quirós JC; Moreno S; Domingo P
    Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():84-104. PubMed ID: 16373008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic vaccines against HIV infection.
    García F; León A; Gatell JM; Plana M; Gallart T
    Hum Vaccin Immunother; 2012 May; 8(5):569-81. PubMed ID: 22634436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic vaccines and immunological intervention in HIV infection: a paradigm change.
    Pantaleo G; Levy Y
    Curr Opin HIV AIDS; 2016 Nov; 11(6):576-584. PubMed ID: 27607591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic vaccination against HIV: current progress and future possibilities.
    Puls RL; Emery S
    Clin Sci (Lond); 2006 Jan; 110(1):59-71. PubMed ID: 16336205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune reconstitution in HIV-1-infected patients.
    Imami N; Hardy G; Pires A; Burton C; Pido-Lopez J; Mela C; Gotch F
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1138-45. PubMed ID: 12211404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Various approaches of therapeutic vaccination for the treatment of HIV type 1 infection].
    Lazrek M; Lobert PE; Goffard A; Schanen C; Dewilde A; Bocket L; Hober D
    Ann Biol Clin (Paris); 2005; 63(6):581-8. PubMed ID: 16330376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of HIV-1 latent reservoirs through therapeutic vaccination.
    Pankrac J; Klein K; Mann JFS
    AIDS Res Ther; 2017 Sep; 14(1):45. PubMed ID: 28893280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune control of HIV-1 reservoirs.
    Autran B; Descours B; Bacchus C
    Curr Opin HIV AIDS; 2013 May; 8(3):204-10. PubMed ID: 23493099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding HIV infection for the design of a therapeutic vaccine. Part II: Vaccination strategies for HIV.
    de Goede AL; Vulto AG; Osterhaus AD; Gruters RA
    Ann Pharm Fr; 2015 May; 73(3):169-79. PubMed ID: 25528627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.
    García F; Climent N; Guardo AC; Gil C; León A; Autran B; Lifson JD; Martínez-Picado J; Dalmau J; Clotet B; Gatell JM; Plana M; Gallart T;
    Sci Transl Med; 2013 Jan; 5(166):166ra2. PubMed ID: 23283367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune.
    Angel JB; Routy JP; Tremblay C; Ayers D; Woods R; Singer J; Bernard N; Kovacs C; Smaill F; Gurunathan S; Sekaly RP
    AIDS; 2011 Mar; 25(6):731-9. PubMed ID: 21330911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunotherapy of HIV infection].
    Harrer T
    Wien Med Wochenschr; 1998; 148(23-24):560-6. PubMed ID: 10189687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.